A Prospective Multi-centre, Noninterventional,observational Post Marketing Surveillance (PMS) Study of RituxiRelTM RN(Rituximab) to Evaluate long-term safety in Patients with Pemphigus Vulgaris in Routine Clinical Practice
Latest Information Update: 29 Jul 2020
At a glance
- Drugs Rituximab (Primary) ; Glucocorticoids
- Indications Pemphigus vulgaris
- Focus Adverse reactions
- Sponsors Reliance Life Sciences
- 29 Jul 2020 New trial record